LianBio
LIANY· OTC
LIANYLianBio
Filed Mar 31, 2022 · 10-K · 90 days after period end · 0001831283-22-000014
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|
| Net Income | -$21.20M | -$12.74M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
LianBio · CIK 1831283 · Engraved from SEC EDGAR
ended Dec 31, 2021 · filed Mar 31, 2022 · 90 d after period end
